Cambrian Genomics, Inc. — Form D/A
Cambrian Genomics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2014-12-19. The offering totals $12.5M, of which $11.2M was reported sold. Industry: Other.
Offering
- Filed: 2014-12-19
- Form: D/A
- Accession: 0001625520-14-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $12.5M
- Amount sold: $11.2M
- Remaining: $1.3M
- Minimum investment: $1
- Investors: 109
- Date of first sale: 2014-11-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-228731
Issuer
- Name: Cambrian Genomics, Inc.
- CIK: 0001625520
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 665 3RD STREET, SUITE 425, SAN FRANCISCO, CA, 94107
- Phone: 619-861-6156
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Austen Heinz | Director | San Francisco, CA |
| Reese Jones | Director | Houston, TX |
| Austen Heinz | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More